Y.S.P.SOUTHEAST ASIA HOLDING

KLSE (MYR): YSPSAH (7178)

You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!

Last Price

2.90

Today's Change

-0.03 (1.02%)

Day's Change

2.88 - 2.95

Trading Volume

64,700

Financial
Market Cap

Market Cap

411 Million

NOSH

142 Million

Latest Quarter

Latest Quarter

31-Mar-2024 [#1]

Announcement Date

21-May-2024

Next Quarter

30-Jun-2024

Est. Ann. Date

22-Aug-2024

Est. Ann. Due Date

29-Aug-2024

QoQ | YoY

69.84% | 27.90%

T4Q Result

Revenue | NP to SH

368,035.000 | 40,332.000

RPS | P/RPS

259.46 Cent | 1.12

EPS | P/E | EY

28.43 Cent | 10.20 | 9.80%

DPS | DY | Payout %

10.00 Cent | 3.45% | 35.04%

NAPS | P/NAPS

2.88 | 1.01

QoQ | YoY

8.09% | 4.04%

NP Margin | ROE

11.12% | 9.87%

F.Y. | Ann. Date

31-Mar-2024 | 21-May-2024

Latest Audited Result

Latest Audited Result

31-Dec-2023

Announcement Date

23-Apr-2024

Next Audited Result

31-Dec-2024

Est. Ann. Date

23-Apr-2025

Est. Ann. Due Date

29-Jun-2025

Annual (Unaudited)

Revenue | NP to SH

354,995.000 | 37,315.000

RPS | P/RPS

250.27 Cent | 1.16

EPS | P/E | EY

26.31 Cent | 11.02 | 9.07%

DPS | DY | Payout %

10.00 Cent | 3.45% | 38.01%

NAPS | P/NAPS

2.79 | 1.04

YoY

8.27%

NP Margin | ROE

10.66% | 9.43%

F.Y. | Ann. Date

31-Dec-2023 | 27-Feb-2024

Annualized Result

Revenue | NP to SH

434,512.000 | 55,328.000

RPS | P/RPS

306.33 Cent | 0.95

EPS | P/E | EY

39.00 Cent | 7.43 | 13.45%

DPS | DY | Payout %

-

NAPS | P/NAPS

-

QoQ | YoY

48.27% | 27.9%

NP Margin | ROE

13.09% | 13.54%

F.Y. | Ann. Date

31-Mar-2024 | 21-May-2024

Business Process

Trailing 4 Quarters Trailing 8 Quarters
Available Quarters 4 Quarters 8 Quarters
Continuous Quarters Of Revenue Growth 1 / 4 25.00% 1 / 8 12.50%
Total Positive Profit Years 4 / 4 100.00% 8 / 8 100.00%
Continuous Quarters Of Positive Profit 4 / 4 100.00% 8 / 8 100.00%
Continuous Quarters Of Profit Growth 2 / 4 50.00% 2 / 8 25.00%
Continuous Quarters Of Adjusted EPS Growth 2 / 4 50.00% 2 / 8 25.00%
Total Dividend Years 1 / 4 25.00% 2 / 8 25.00%
Continuous Quarters Of Dividend 0 / 4 0.00% 0 / 8 0.00%
Continuous Quarters Of Dividend Growth 0 / 4 0.00% 0 / 8 0.00%
Continuous Quarters Of Adjusted Dps Growth 0 / 4 0.00% 0 / 8 0.00%
Average ROE 2.57% 2.61%
Average Net Profit Margin 11.15% 11.22%

Last 5 Financial Years Last 10 Financial Years
Available Years 5 Years 10 Years
Continuous Quarters Of Revenue Growth 2 / 5 40.00% 2 / 10 20.00%
Total Positive Profit Years 5 / 5 100.00% 10 / 10 100.00%
Continuous Quarters Of Positive Profit 5 / 5 100.00% 10 / 10 100.00%
Continuous Quarters Of Profit Growth 2 / 5 40.00% 2 / 10 20.00%
Continuous Quarters Of Adjusted EPS Growth 2 / 5 40.00% 2 / 10 20.00%
Total Dividend Years 5 / 5 100.00% 10 / 10 100.00%
Continuous Quarters Of Dividend 5 / 5 100.00% 10 / 10 100.00%
Continuous Quarters Of Dividend Growth 2 / 5 40.00% 2 / 10 20.00%
Continuous Quarters Of Adjusted Dps Growth 2 / 5 40.00% 2 / 10 20.00%
Average ROE 7.31% 8.16%
Average Net Profit Margin 8.30% 9.30%
Key Result

T4Q Annualized Annual (Unaudited) Last 10 FY Average Last 5 FY Average
Revenue 368,035 434,512 354,995 277,631 312,756
NP to SH 40,332 55,328 37,315 25,573 26,390
Dividend 14,133 0 14,182 10,917 11,952
Adjusted EPS 28.43 39.00 26.31 18.03 18.60
Adjusted DPS 10.00 0.00 10.00 7.70 8.43

NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share

All figures in '000 unless specified.

EPS & DPS's figures in Cent.

Growth

LQ QoQ LQ YoY CQ YoY LQ vs Average of T4Q LQ vs Average of T8Q
Revenue 21.61% 13.64% 13.64% 18.06% 21.32%
NP to Owner 69.84% 27.90% 27.90% 37.18% 39.90%
Dividend 0.00% 0.00% 0.00% 0.00% 0.00%
Adjusted EPS 69.82% 27.88% 27.88% 37.17% 39.88%
Adjusted DPS 0.00% 0.00% 0.00% 0.00% 0.00%

LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year

T4Q vs LFY T4Q vs AL5FY T4Q vs AL10FY AQR vs LFY AQR vs AL5FY AQR vs AL10FY LFY YoY LFY vs AL5FY LFY vs AL10FY
Revenue 3.67% 17.67% 32.56% 22.40% 38.93% 56.51% 6.21% 13.51% 27.87%
NP to Owner 8.09% 52.83% 57.71% 48.27% 109.65% 116.35% 8.27% 41.40% 45.91%
Dividend -0.35% 18.24% 29.45% 0.00% 0.00% 0.00% 25.71% 18.66% 29.90%
Adjusted EPS 8.07% 52.81% 57.69% 48.25% 109.62% 116.31% 8.27% 41.40% 45.91%
Adjusted DPS 0.01% 18.67% 29.92% 0.00% 0.00% 0.00% 25.71% 18.66% 29.90%

T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year

Discussions
6 people like this. Showing 50 of 2,077 comments

Lightofheaven

Hold for long term
The profit is promising

2021-08-30 13:55

wallstreetrookie

Sympathy play alongside Apex and IHH

2021-09-01 15:14

ValueMe

Wow!so many gamblers here.

2021-09-01 15:46

wallstreetrookie

What do you mean so many? There is only one comment today

2021-09-01 15:51

MohismMoTzu

gamblers ? i thought most of us will forget we owned this stock until we received a cheque notice about the dividend . hahaha

2021-09-01 16:19

Lightofheaven

As i mentioned, hold long term for good profit
Refered to my message on 30/8/21

2021-09-01 16:59

MohismMoTzu

why today all the medicine stock go up ?

2021-09-01 17:27

Lightofheaven

Hold jer..for long for sure the return is good

2021-09-02 15:03

ValueMe

Hold sampai tumbuh janggut putih.Kihkihkih.

2021-09-18 15:04

Lightofheaven

Hold for lomg term.
2 years like that.
You will thanks me.
Just a cup of starbuck belanja me.

2021-09-22 11:31

wallstreetrookie

Initiate position

2021-10-04 16:31

maska

more medicine supply

2022-01-24 15:46

wallstreetrookie

Guide to Investing in Bursa Healthcare 2022
1. Kotra Industries 2. YSP 3. ???

2022-04-02 21:53

UnicornP

Agreed with csan. Undervalued and going to be more undervalued!

2022-09-15 15:09

UnicornP

Creeping up

2022-10-31 10:32

wallstreetrookie

Buy-side has no more idea. They will pump all the healthcare stocks remaining

2022-11-04 11:22

wallstreetrookie

Just look at all the non-glove companies. They are all green

2022-11-04 11:22

UnicornP

Gross got up a bit, still good. Confident prospect.

2022-11-22 19:32

UnicornP

csan sell call

2022-12-01 16:40

Lightofheaven

Yes. Yes. Yes
Hold until next year Autumn for great harvest

2022-12-05 09:57

Lightofheaven

Y.S.P remain strong and healthy..all the way towards 2023

2022-12-12 16:23

Lightofheaven

walao ehh..wat happen to YSP
Suddenly surge to fly so high today!! Happy Happy

2022-12-13 12:48

Thkent91

Finally this share has released it's true potential power. I have been waiting years for it to shine

2023-01-03 19:55

wallstreetrookieNEW

Apex Healthcare + YSP + Kotra Industries = Dream Healthcare Portfolio 2023

2023-02-23 16:34

wallstreetrookieNEW

All in

2023-02-23 16:34

pang72

QR gostan?
So, largely pump and dump for HEALTHCARE recently

2023-02-27 19:11

value_seeker

Is the breakout sustainable?

2023-02-27 20:41

hhhiii123

What happen to the price when qtr result so good, any insider news?

2023-02-28 21:35

Nighelanghelo

someone keyed in 2.49 instead of 2.94?

2023-03-01 13:36

Integrity. Intelligent. Industrious. 3iii (iiinvestsmart)$€£¥

Security LastPr PE DY% Divcts ROE ttm-marg
YSPSAH (Pharmaceuticals) 2.35 9.63 3.4 8 9.25 10.3

2023-03-30 17:12

Lightofheaven

hold this for long term
hold this for dividen

2023-08-01 12:25

katara

good counter

2023-08-03 16:43

katara

no one interested?💙

2024-01-05 14:18

donald770

Qr result best ever. Should be due for upside rerating!!!

1 month ago

BullishMarket

New Production line is started to be operated for the newly acquired factory premise. With the newly operated production line, the company's Revenue YoY % growth will be significantly increased within 2 years.

1 month ago

Papayashot

Hi BullishMarket, from where you aware that New Production line is started to be operated for the newly acquired factory premise?

1 month ago

SincereStock

bought a few at 2.85, acceptable bargain I think considering today open at RM3

1 month ago

katara

mid term TP 330-450

1 month ago

katara

today steady at 295😘

1 month ago

katara

going to fly .. .. ..

1 month ago

TiffanixLVxHermes

reasons to buy:
1. recorded highest revenue and profit in 20years
2. organic growth, hold patents (expect to continue deliver good result)
3. DY 3.5% above RM0.11 ex 24/6/24

let's monitor
😎

1 month ago

xiaoeh

Dear TLVH
may i know your entry price...?

1 month ago

TiffanixLVxHermes

above 2.90 😎

1 month ago

xiaoeh

Noted and Thanks for your sharing👍

1 month ago

Up_down

Yspsah has been all the while being the lowest valuation company against its peers like Ahealth & Dpharma.

1 month ago

katara

next monday 11 sen ex😍

2 weeks ago

katara

https://www.ctee.com.tw/news/20220714700772-439801
永信東南亞控股是台灣本土學名藥製藥廠中,第一家跨國上市的公司。這兩年,受疫情影響,年營收成長仍有3%〜5%。即將來臨的後疫情時代,李芳信預計,自2022年起,公司營收至少有雙位數以上的成長。

3 days ago

Post a Comment